Endothelial VCAM1 links oncogenic KRAS signaling to myeloid inflammation and hemorrhagic instability in brain arteriovenous malformations

BACKGROUND: Hemorrhagic conversion is the most devastating complication of brain arteriovenous malformations (bAVMs). However, endothelial mechanisms promoting macrophages (Mφ) recruitment, microglia (MG) activation, and bAVM lesion instability remain unclear. We investigated vascular cell adhesion molecule-1 (VCAM1) as a mediator linking oncogenic endothelial signaling to myeloid cell responses and hemorrhagic progression in bAVMs. METHODS: We performed integrated transcriptomic analysis of human bAVM and epilepsy-control brain tissues, with validation in local bAVM specimens. Transcriptomic and proteomic analyses of bAVM lesions and intact brain tissues from mutant KRAS-induced bAVM mice were followed by histological validation. Using AAV-BR1-KRASG12V-injected Cx3cr1-gfp;Ccr2-rfp mice, we performed intravital imaging to assess Mφ/MG responses to VCAM1 neutralization. Hemorrhage and myeloid cell responses were also evaluated following endothelial-specific VCAM1 deletion. Plasma soluble VCAM1 (sVCAM1) was measured in patients with unruptured and ruptured bAVMs and unruptured aneurysm controls. Effects of sVCAM1 on MG activation were examined in vitro. RESULTS: Integrated human endothelial bulk and single-cell RNA-sequencing and tissue validation identified VCAM1 upregulation in bAVMs, including unruptured lesions. Plasma analyses showed increased sVCAM1 in unruptured and ruptured bAVM patients compared with unruptured aneurysm controls. In mutant KRAS-induced bAVM mice, transcriptomic and proteomic analyses demonstrated increased VCAM1 expression, with endothelial localization confirmed histologically. In vitro, mutant KRAS increased sVCAM1 production, while recombinant sVCAM1 stimulated inflammatory mediator expression in MG. Both MG and Mφ expressed VLA-4, a major VCAM1 receptor. Intravital imaging showed that VCAM1 neutralization reduced Mφ accumulation and MG activation, while early VCAM1 neutralization reduced hemorrhagic burden. Consistently, endothelial-specific VCAM1 deletion reduced Mφ accumulation, MG activation, and hemorrhage volume in bAVM mice and improved behavioral performance. CONCLUSIONS: These findings identify endothelial VCAM1 as an upstream mediator linking mutant KRAS signaling to myeloid cell responses and hemorrhagic progression in bAVMs. This study establishes endothelial VCAM1 as a potential therapeutic target for attenuating hemorrhagic progression.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.15.766869
Primary Topic
Vascular Malformations Diagnosis and Treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Endothelial VCAM1 links oncogenic KRAS signaling to myeloid inflammation and hemorrhagic instability in brain arteriovenous malformations

Zhongming Zhao, Huimahn Alex Choi, Eun Su Park, Jaroslaw A Aronowski et al.
4 links
bioRxiv (Cold Spring Harbor Laboratory)
Vascular Malformations Diagnosis and Treatment
preprint

Endothelial VCAM1 links oncogenic KRAS signaling to myeloid inflammation and hemorrhagic instability in brain arteriovenous malformations

Zhongming Zhao, Huimahn Alex Choi, Eun Su Park, Jaroslaw A Aronowski, Xian Chen, Jakob Körbelin, Jong Min Choi, Jung-Eun Park, Sung Yun Jung, Peng Roc Chen, Eunhee Kim, Ohnmar Myint, Shuning Huang, Sung Wook Kang, Hyejin Park
preprint en

Abstract

BACKGROUND: Hemorrhagic conversion is the most devastating complication of brain arteriovenous malformations (bAVMs). However, endothelial mechanisms promoting macrophages (Mφ) recruitment, microglia (MG) activation, and bAVM lesion instability remain unclear. We investigated vascular cell adhesion molecule-1 (VCAM1) as a mediator linking oncogenic endothelial signaling to myeloid cell responses and hemorrhagic progression in bAVMs. METHODS: We performed integrated transcriptomic analysis of human bAVM and epilepsy-control brain tissues, with validation in local bAVM specimens. Transcriptomic and proteomic analyses of bAVM lesions and intact brain tissues from mutant KRAS-induced bAVM mice were followed by histological validation. Using AAV-BR1-KRASG12V-injected Cx3cr1-gfp;Ccr2-rfp mice, we performed intravital imaging to assess Mφ/MG responses to VCAM1 neutralization. Hemorrhage and myeloid cell responses were also evaluated following endothelial-specific VCAM1 deletion. Plasma soluble VCAM1 (sVCAM1) was measured in patients with unruptured and ruptured bAVMs and unruptured aneurysm controls. Effects of sVCAM1 on MG activation were examined in vitro. RESULTS: Integrated human endothelial bulk and single-cell RNA-sequencing and tissue validation identified VCAM1 upregulation in bAVMs, including unruptured lesions. Plasma analyses showed increased sVCAM1 in unruptured and ruptured bAVM patients compared with unruptured aneurysm controls. In mutant KRAS-induced bAVM mice, transcriptomic and proteomic analyses demonstrated increased VCAM1 expression, with endothelial localization confirmed histologically. In vitro, mutant KRAS increased sVCAM1 production, while recombinant sVCAM1 stimulated inflammatory mediator expression in MG. Both MG and Mφ expressed VLA-4, a major VCAM1 receptor. Intravital imaging showed that VCAM1 neutralization reduced Mφ accumulation and MG activation, while early VCAM1 neutralization reduced hemorrhagic burden. Consistently, endothelial-specific VCAM1 deletion reduced Mφ accumulation, MG activation, and hemorrhage volume in bAVM mice and improved behavioral performance. CONCLUSIONS: These findings identify endothelial VCAM1 as an upstream mediator linking mutant KRAS signaling to myeloid cell responses and hemorrhagic progression in bAVMs. This study establishes endothelial VCAM1 as a potential therapeutic target for attenuating hemorrhagic progression.

bioRxiv (Cold Spring Harbor Laboratory)
Bayer (United States) (US), Baylor College of Medicine (US), University Medical Center Hamburg-Eppendorf (DE), University of Houston (US), The University of Texas Health Science Center at Houston (US)
Cancer Prevention and Research Institute of Texas, National Institutes of Health
Good health and well-being
Vascular Malformations Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon